Agenda 
                                    Medicare Evidence Development & Coverage Advisory Committee 
                                                             November 9, 2011 
                                                            7:30 AM – 4:30 PM 
                                                             CMS Auditorium 
                              
               Clifford Goodman, PhD, Chair 
               Steve Phurrough, MD, Vice Chair 
               James Rollins, MD, Division Director, Division of Items and Devices, Coverage and Analysis Group 
               Maria Ellis, Executive Secretary 
               ----------------------------------------------------------------------------------------------------------------------------------- 
               7:30 – 8:00 AM                   Registration  
                
               8:00 – 8:15 AM                   Opening Remarks— Maria Ellis/James Rollins, MD/Clifford Goodman, PhD 
                
               8:15 - 8:25 AM                   CMS Presentation & Voting Questions – Lisa Eggleston, RN, MS 
               8:25 – 9:05 AM                   Rob MacLeod, PhD, 
                                                                     Associate Professor of Bioengineering and Internal 
                                                Medicine University of Utah Scientific Computing and Imaging (SCI) 
                                                Institute 
               9:05 – 9:25 AM                   Jerome L. Fleg, MD, National Heart, Lung and Blood Institute, National 
                                                Institutes of Health 
                
                9:25 – 10:00 AM                 TA Presentation: Remy R. Coeytaux. MD, PhD,  Associate Professor, 
                                                Community and Family Health Medicine, Duke Clinical Research Institute and 
                                                Philip Leisy, BS, MD Candidate, ECU Brody School of Medicine 
                
               10:00 – 10:15 AM                 BREAK            
                
               10:15 – 11:00 AM                 Scheduled Public Comments 
                                                (Refer to Speaker List) 
               ****************************************************************************** 
               Public attendees, who have contacted the executive secretary prior to the meeting, will address the panel and 
               present information relevant to the agenda. Speakers are asked to state whether or not they have any financial 
               involvement with manufacturers of any products being discussed or with their competitors and who funded their 
               travel to this meeting.  
               ****************************************************************************** 
               11:00 – 11:15 AM                 Open Public Comments 
                
               Public Attendees who wish to address the panel will be given that opportunity  
                
               11:15 – 12:00 PM                 Questions to Presenters 
                
               12:00 – 1:00 PM                  LUNCH (on your own) 
                
               1:00 – 2:00 PM                   Initial Open Panel Discussion: Dr. Goodman 
                
               2:00 – 3:00 PM                   Formal Remarks and Voting Questions  
               The Chairperson will ask each panel member to state his or her position on the voting questions.  
                
               3:00 – 4:00 PM                   Final Open Panel Discussion: Dr. Goodman 
                
               4:00 – 4:30 PM                   Closing Remarks/Adjournment: Dr. Rollins & Dr. Goodman